The Biden administration hopes that the boosters, formulated to target the prevalent subvariants of the omicron variant, willprovide better protection against infection and severe disease, but it's unclear how large an additional effect it will have given that much of the population has already been vaccinated, been exposed to the omicron variant, or both.